Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Apolipoprotein-E epsilon 4 (APOE-epsilon 4) has been consistently associated with Alzheimer disease (AD) and may be responsible for an earlier age at onset. We have previously reported a diminished association between APOE-epsilon 4 and AD in African Americans. Using a new method, which allows inclusion of censored information, we compared relative risks by APOE genotypes in an expanded collection of cases and controls from three ethnic groups in a New York community. The relative risk for AD associated with APOE-epsilon 4 homozygosity was increased in all ethnic groups (African American relative risk [RR]=3.0; 95% confidence interval [CI]=1.5-5.9; Caucasian RR=7.3, 95% CI=2.5-21.6; and Hispanic RR=2.5, 95% CI=1.1-5.7), compared with those with APOE-epsilon 3/epsilon 3 genotypes. The risk was also increased for APOE-epsilon 4 heterozygous Caucasians (RR=2.9, 95% CI=1.7-5.1) and Hispanics (RR=1.6, 95% CI=1.1-2.3), but not for African Americans (RR=0.6, 95% Ci=0.4-0.9). The age distribution of the proportion of Caucasians and Hispanics without AD was consistently lower for APOE-epsilon 4 homozygous and APOE-epsilon 4 heterozygous individuals than for those with other APOE genotypes. In African Americans this relationship was observed only in APOE-epsilon 4 homozygotes. These results confirm that APOE genotypes influence the RR of AD in Caucasians and Hispanics. Differences in risk among APOE-epsilon 4 heterozygote African Americans suggest that other genetic or environmental factors may modify the effect of APOE-epsilon 4 in some populations.

[1]  M. Savolainen,et al.  Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians. , 1994, Atherosclerosis.

[2]  B. Turnbull.  Nonparametric Estimation of a Survivorship Function with Doubly Censored Data , 1974 .

[3]  J. Growdon,et al.  Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19 , 1993, The Lancet.

[4]  L. Kuller,et al.  Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. , 1993, The American journal of cardiology.

[5]  S. Sorbi,et al.  ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease , 1994, Neuroscience Letters.

[6]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[7]  G. Schellenberg,et al.  Apolipoprotein E genotype and Alzheimer's disease , 1993, The Lancet.

[8]  S. Srinivasan,et al.  Apolipoprotein E polymorphism and its association with serum lipoprotein concentrations in black versus white children: the Bogalusa Heart Study. , 1993, Metabolism: clinical and experimental.

[9]  J. Mak,et al.  Effect of apolipoprotein E variants on plasma lipids and apolipoproteins in the Orang Asli ('aborigines') of Malaysia. , 1994, Human heredity.

[10]  E L Kaplan.  NON-PARAMETRIC ESTIMATION FROM INCOMPLETE OBSERVATION , 1958 .

[11]  J. Teresi,et al.  Relative Rates of Dementia By Multiple Case Definitions, Over Two Prevalence Periods, In Three Sociocultural Groups. , 1995, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[12]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[13]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[14]  D. Arveiler,et al.  Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  T. Hänninen,et al.  Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study , 1994, BMJ.

[16]  P. Majumder,et al.  Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. , 1989, American journal of human genetics.

[17]  A. Roses.  Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease , 1995, Annals of neurology.

[18]  R. Ferrell,et al.  Genetic studies of human apolipoproteins. VI. Common polymorphism of apolipoprotein E in blacks. , 1989, Disease markers.

[19]  J. Stengård,et al.  Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. , 1995, Circulation.

[20]  A. Roses.  Genetic associations , 1998, The Lancet.

[21]  P A Wolf,et al.  Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. , 1994, JAMA.

[22]  O. Gureje,et al.  Lack of an association between apolipoprotein E ϵ4 and Alzheimer's disease in elderly nigerians , 1995 .

[23]  R. D'Agostino,et al.  Using survival methods to estimate age‐at‐onset distributions for genetic diseases with an application to Huntington disease , 1989, Genetic epidemiology.

[24]  C. Sing,et al.  The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. , 1992, American journal of human genetics.

[25]  Bruce G. Link,et al.  Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis. , 1992, Archives of neurology.

[26]  K. Marder,et al.  Consistency of clinical diagnosis in a community-based longitudinal study of dementia and Alzheimer's disease , 1995, Neurology.

[27]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[28]  L A Beckett,et al.  Age-specific incidence of Alzheimer's disease in a community population. , 1995, JAMA.

[29]  M. Owen,et al.  Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease. , 1994, Journal of medical genetics.

[30]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[31]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[32]  M. Pericak-Vance,et al.  Clinical application of apolipoprotein E genotyping to Alzheimer's disease , 1994, The Lancet.

[33]  B. Tycko,et al.  Apolipoprotein E and alzheimer's disease: Ethnic variation in genotypic risks , 1995, Annals of neurology.

[34]  E. Boerwinkle,et al.  The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. , 1991, American journal of human genetics.

[35]  M. Rossor,et al.  Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. , 1994, Human molecular genetics.

[36]  G. Utermann,et al.  High frequency of the apo epsilon 4 allele in Khoi San from South Africa. , 1995, Human genetics.

[37]  P. Froguel,et al.  Genetic associations with human longevity at the APOE and ACE loci , 1994, Nature Genetics.

[38]  Denis A. Evans.  Prevalence of Alzheimer's Disease-Reply , 1990 .

[39]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[40]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Tilvis,et al.  Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[42]  G. Schellenberg,et al.  Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans , 1995, Annals of neurology.

[43]  B. Winblad,et al.  Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. , 1994, Neuroscience letters.